期刊文献+

地诺前列酮栓在非胰岛素治疗的妊娠期糖尿病足月妊娠引产中临床分析 被引量:3

Clinical analysis on dinoprostone suppositories used for induced labor of full-term pregnancy of cases with gestational diabetes mellitus and without insulin treatment
原文传递
导出
摘要 目的:探讨地诺前列酮(欣普贝生)用于非胰岛素治疗的足月妊娠期糖尿病引产的有效性及安全性。方法:选择有引产指征的非胰岛素治疗的足月妊娠期糖尿病孕妇79例,其中欣普贝生组48例,对照组(催产素组)31例,比较两组的引产效果及分娩情况。结果:实验组促宫颈成熟率为93.75%,对照组为48.39%,实验组用药至临产时间、总产程均短于对照组,剖宫产率低于对照组,差异有统计学意义(P<0.01),实验组在产后出血、胎儿窘迫、分娩期血糖变化方面与对照组差异无统计学意义。结论:非胰岛素治疗的妊娠期糖尿病足月妊娠应用地诺前列酮栓引产与催产素相比成功率高、产程短,可提高阴道分娩率,降低剖宫产率,是安全有效的引产方式,值得临床推广。 [Abstract] Objective: To explore the effectiveness and safety of dinoprostone suppositories used for induced labor of full - term pregnancy of cases with gestational diabetes mellitus ( GDM ) and without insulin treatment. Methods: A total of 79 full - term pregnant women with GDM and the indications of induced labor and without insulin treatment were selected, including 48 cases in experimental group ( dinoprestone suppositories group) and 31 cases in control group ( oxytocin group) ; the effects of induced labor and delivery conditions in the two groups were compared. Results: The rates of cervical ripening in experimental group and control group were 93.75% and 48.39 %, respectively; the interval time from drug therapy to parturiency and the total stage of labor in experimental group were shorter than those in control group, the rate of cesarean section in experimental group was lower than that in control group, there was statistically significant differ- ence ( P 〈 0.01 ) ; there was no statistically significant difference in the incidences of postpartum hemorrhage and fetal distress, the changes of blood glucose during delivery period between the two groups. Conclusion : Compared with oxytocin, dinoprostone suppositories used for in- duced labor of full - term pregnancy of cases with GDM and without insulin treatment had the advantages of high successful rate and short sta- ges of labor, which can improve the rate of vaginal delivery and reduce the rate of cesarean section, and the method is safe and effective for induced labor, and it is worthy to be popularized in clinic.
出处 《中国妇幼保健》 CAS 北大核心 2012年第21期3246-3248,共3页 Maternal and Child Health Care of China
关键词 妊娠期糖尿病 地诺前列酮栓 引产 宫颈成熟 Gestational diabetes mellitus Dinoprostone suppositories Induced labor Cervical ripening
  • 相关文献

参考文献7

  • 1Mukhopadhyay M, Lim K J, Fairlie FM. Is propess a better method of induction of labour in nulliparous women [ J ] . J Obstet Gynaecol, 2002, 22 (3): 294.
  • 2Arduini M, Giri C, Giannone Let al. Prepidil versus Propess : pharmacological induction of labour with dinoprostone [J] . Minerva Ginecol, 2008, 60 (2): 127.
  • 3Vollebregt A, van t Hof DB, Exalto N. Prepidil compared to Propess for cervical ripening [ J ] . Eur J Obstet Gynecol Re- prod Biol, 2002, 104 (2): 116.
  • 4Witter FR. Prostaglandin E2 preparations for preinduction cervi- cal ripening [ J]. Clin Obstet Gynecol, 200, 43 (3) : 469.
  • 5吴玲玲,张媛,范建辉,林颖,侯红瑛.欣普贝生应用于足月胎膜早破引产的临床分析[J].中国医药,2010,5(11):1051-1053. 被引量:10
  • 6张淑兰.糖尿病.见:乐杰主编.妇产科学[M].第7版,北京:人民卫生出版社,2008:150-154.
  • 7Ramsey PS, Meyer L, Walkes BA et al. Cardiotocographic ab- normalities associated with dinoprostone and misoprostol cervi- cal ripening [J] . Obstet Gynecol, 2005, 105 : 85.

二级参考文献12

  • 1魏丽,费英俊.控释前列腺素E_2栓剂-普贝生引产的临床观察与护理[J].实用药物与临床,2007,10(3):200-200. 被引量:5
  • 2Witter FR.Prostaglandin E2 preparations for preinduction cervical ripening.Clin Obstet Gyneco1,2000,43(3):469-474.
  • 3Rath W.A clinical evaluation of controlled-release dinoprostone for cervical ripening--a review of current evidence in hospital and outpatient settings.J Perinat Med,2005,33(6):491-499.
  • 4Mazouni C,Provensal M,Ménard JP,et al.Evaluation of controlled-release dinoprostone Propess for labor induction.Gynecol Obstet Ferti1,2006,34(6):489-492.
  • 5Larrafiaga-Azcárate C,Campo-Molina G,Pérez-Rodríguez AF,et al.Dinoprostone vaginal slow-release system(Propess)compared to expectant management in the active treatment of premature rupture of the membranes at term:impact on maternal and fetal outcomes.Acta Obstet Gynecol Scand,2008,87(2):195-200.
  • 6Lyren(a)s S,Clason I,Ulmsten U.In vivo controlled release of PGE2 from a vaginal insert(0.8 mm,10 mg)during induction of labour.BJOG,2001,108(2):169-178.
  • 7Strobelt N,Meregalli V,Ratti M.Randomized study on removable PGE2 vaginal insert versus PGE2 cervical gel for cervical priming and labor induction in low-Bishop-score pregnancy.Acta Obstet Gynecol Scand,2006,85(3):302 -305.
  • 8Rozenberg P,Chevret S,Senat MV.A randomized trial that compared intravaginal misoprostol and dinoprostone vaginal insert in pregnancies at high risk of fetal distress.Am J Obstet Gynecol,2004,191(1):247-253.
  • 9李华.前列腺素E_2引产的观察和护理[J].中国基层医药,2007,14(11):1926-1927. 被引量:1
  • 10杨青,邹敬伟,张亚楠.前列腺素E_2用于足月妊娠引产100例临床观察[J].实用药物与临床,2008,11(1):15-16. 被引量:2

共引文献9

同被引文献21

  • 1BLUMENTFELD Y J, LEE H C, GOULD J B, el al. The effect of preterm premature repture of membranes on neonatal mortality rates [ J]. Obstet Gynecol, 2010, 116(6):1381-1386.
  • 2GRIGNAFFINI A, SONCINI E, ANFUSO S, et al. Dino- prostone: slow release vaginal insert (Propess) and intracervical gel (Prepidil) for the induction of labour with unriped cervix [ J]. Minerva Ginecol,2004,56 ( 5 ) :413.
  • 3FOK W Y, LEUNG T Y, TSUI M H, et al. Effect of prostaglandin E2 for cervical priming on fetal hemodynamics [ J ]. J Reprod Med,2005,50 (9) :697.
  • 4VOLLEBREGT A, VAN'T HOF D B, EXALTO N. Prepidil compared to Propess for cervical ripening [ J ]. Eur J Obstet Gynecol Reprod Biol, 2002,104 (2) : 116-119.
  • 5WITFER F R. Prostaglandin E2 preparations for preindu- ction cervical ripening [ J ]. Clin Obstet Gynecol, 200,43 (3) : 469-474.
  • 6LYREN AS S, CLASON I,ULMSTEN U. In vivo controlled release ofPGE2 from a vaginal insert( 0. 8 ram, 10 rag) during induction of labour[J].Br J Obstet Gynaecol,2001, 108(2) :169-178.
  • 7TAN P C,DAUD S A,OMAR S Z. Concun'ent dinoprostone and oxytocin for labor induction in term premature rupture ofmembranes [ J ]. Obstet Gynecol, 2009,113 ( 5 ) : 1059- 1065.
  • 8SALVADOR S C, SIMPSON M L, CUNDIFF G W. Dino- prostone vaginal insert for labour induction: a comparison of outpatient and inpatient settings [ J ]. J Obstet Gynaecol Can,2009,31(11) : 1028-1034.
  • 9LARANAGA-AZCARATE C, CAMPO-MOLINA G, PEREZ- RODRNGUEZ A F, et al. Dinoprostone vaginal slow-release system (Propess) compared to expect ant management in the active treatment of premature rupture of the membranes at term: impact on maternal and fetal out comes [ J]. Acta Obstet Gynecol Scand ,2008,87 ( 2 ) : 195-200.
  • 10马锦琪,陈建英,荣琴英,张金伟,吴伟燕.欣普贝生用于足月妊娠引产21例临床分析[J].江苏医药,2010,36(17):2095-2096. 被引量:1

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部